Download Download

Total Page:16

File Type:pdf, Size:1020Kb

Download Download Free Neuropathology 1:25 (2020) Kurt A. Jellinger doi: https://doi.org/10.17879/freeneuropathology-2020-2945 page 1 of 20 Reflections Neuropathology through the ages My life between neurology and neuropathology 1 Kurt A. Jellinger 1 Institute of Clinical Neurobiology, Vienna, Austria Address for correspondence: Kurt A. Jellinger · Institute of Clinical Neurobiology · Alberichgasse 5/13 · A-1150 Vienna · Austria [email protected] Additional resources and electronic supplementary material: supplementary material Submitted: 12 August 2020 · Accepted: 12 August 2020 · Copyedited by: Katy Lawson · Published: 27 August 2020 Keywords: Neuropathology, Clinical neurology, Vienna, Personal reflections Introduction enced by my late mother, my beloved wife Elisa- beth, colleagues, patients, friends, and students When the editors of Free Neuropathology, whom I met during my professional and private life. Werner and Tibor, approached me about writing an autobiography for the journal, similar in scope to This essay is intended to encourage young col- Sam Ludwin’s excellent piece two years ago [1], I leagues to not concentrate exclusively on experi- confess that I had reservations about writing an mental neuropathology without also considering autobiography, because I never wanted to talk the practical part of the neurosciences since there about myself. However, after a lengthy hesitation is an urgent need to inspire young neurologists to and eager discussions with my wife and my former pursue a double career as both a clinician and neu- scholar and friend, Hans Lassmann, I realized with a roscientist in order to promote progress in the neu- certain degree of doubt that, on the threshold of rosciences. age 90 years, I could perhaps provide some thoughts about the bridges between clinical neu- Why the appeal of clinical neurology rology and neuropathology for those who might be and neuropathology? interested in the experiences of an old neuroscien- tist. There are three principal reasons to try to uni- Thus, in lieu of concentrating on my career as fy these two closely connected fields of neurosci- neuropathologist, I wish to instead write about my ence. First and foremost is the aim to help patients life in the context of unifying these intrinsically suffering from disorders of the nervous system by linked but disparate areas within the rapidly pro- trying to make an early diagnosis, provide effective gressing scientific world: neurology and neuropa- treatment, and promote preventive measures. thology. This long, and not always easy, path Second, is the ongoing need to apply ever-evolving through the wide field of practical and theoretical basic scientific approaches to diseases of the nerv- neuroscience, as well as other interests, was influ- ous system in order to support the clinical neurolo- Copyright: © 2020 The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited, a link to the Creative Commons license is provided, and any changes are indicated. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Free Neuropathology 1:25 (2020) Kurt A. Jellinger doi: https://doi.org/10.17879/freeneuropathology-2020-2945 page 2 of 20 gist in elucidating the pathogenesis of disorders After Austria's “Anschluss” to the German afflicting their patients. Neuropathology should be Reich, I attended a public primary school in Vienna pursued not just for its own sake but to aid the and later, during World War II, a public secondary clinician with the mutual goal to improve diagnoses school (Realgymnasium, also in Vienna), where I and enable successful therapeutic strategies for received basic education in languages, natural sci- many hitherto incurable disorders. Lastly, there is ences, geography, and history. In 1943, to escape inherent fascination and fulfillment in using our from air raids on the city, many children were sent knowledge to elucidate the structure and function to live with farmers in the Batschka, then southern of the nervous system in the healthy and diseased Hungary, now Serbia. Once there, we had a won- human individual. derful and peaceful time, though the atrocity of witnessing the pogroms of Jewish people was never Based on this knowledge, the neuropa- far from sight or mind. thologist is able to elucidate much of the back- ground of disorders of the nervous system using On our way home we passed the then peace- immunohistochemical, molecular, biological, and ful city of Budapest, which I would see again during ultrastructural methods not only in autopsy mate- the Hungarian revolution in 1956. Once returned to rial but also tissues from living patients, including Vienna, in 1944, we had to change school buildings biopsies, cerebrospinal fluid, and blood. Often, due to bombing damages. Air raids were still so these images are comparable to modern art (Fig. frequent that I often did not make it home in the 1). The selective and interdisciplinary application of evenings but had to instead seek shelter along the these methods may enable the neuropathologist to way. not only make a reasonable diagnosis of many, though not all, disorders of the nervous system but In September of 1944, we lost our home due may also provide insight into the complex pathoge- to an air raid and had to wait for a new flat. Around netic cascades that are responsible for the onset this time, I attended one of the last performances and progression of such disorders. In this respect, of Schiller's Wallenstein trilogy of plays featuring the neuropathologist is privileged to act as both a the famous actor Werner Krauss in the Vienna Burgtheater. Soon afterwards, all theaters were physician and a basic scientist. closed. On April 13, 1945, during the battle be- This retrospective will consider highlights and tween German and Russian armies in the city of drawbacks in my 63 years of life between clinical Vienna, I had my first medical “experience” by neurology, neuropathology, and private activities. cleaning up brain tissue of Russian soldiers who Given my many years of work and limited space were killed by the projectile from a German tank. herein, may my friends, scholars, colleagues, and After my father died in a Russian POW camp in co-workers excuse that I regrettably could not con- 1947, my mother and I were left alone to overcome sider all of them in this review. the difficult times after the end of the war. She worked in her former profession as a dressmaker Early life and schooling and I became tutor of children. In 1949, I graduated high school summa cum I was born May 28, 1931 in Vienna, as the only laude. In that final year, our class contained 18 child to Rosa and Alois Jellinger, both with roots boys and, when we had our final exams, I got excel- from Upper Austria and Moravia (near Olomouc). lent marks (Fig. 2). After graduation, our class, led My father was an official in the government of by our Latin teacher, traveled to Rome and Naples, Lower Austria; my mother, a trained dressmaker, where we enjoyed arts, cuisine, and life in Italy. To was a housewife. In the prewar years, I had a won- this day, I remain grateful to my many teachers derful and well-kept childhood filled with summer who encouraged me to liberally approach history vacations in the beautiful surroundings of Vienna and natural sciences. Years later, one of my favorite and in the idyllic countryside, while in the city there high school teachers became a patient in my clinic were increasing tensions, poverty, and changes in with myasthenia gravis, which we treated with the political atmosphere. I remember Kurt success. Over the years, my classmates and I met Schuschnigg's radio speech of March 11, 1938, with several times at reunions to remember and discuss his concluding sentence “May God protect Austria,” previous experiences. The last meeting was 2009 to after which my father commented, “This will be the celebrate the 50th anniversary of our graduation. beginning of the end.” Free Neuropathology 1:25 (2020) Kurt A. Jellinger doi: https://doi.org/10.17879/freeneuropathology-2020-2945 page 3 of 20 Fig. 1. (A) MS-like autoimmune encephalitis after repeated subcutaneous injections of lyophilized calf brain cells in male aged 51 years with hemi-Parkinson syndrome. Left hemisphere with prominent periventrivular demyelinated lesion and multiple demyelinated plaques in cortex and subcortical nuclei. From [2] (B) EM image of focal (core) plaque in hippocampus showing dense accumulation of thick amyloid fiber bundles, surrounded by dystrophic neuritic endings and hyperintense structure of myelinated axon. (x 4000). Photo: K.A. Jellinger. (C) Major histopathological changes in Alzheimer’s disease. (C1) Amyloid deposits in the neuropil (plaques) and vascula- ture (CAA) (congo red stain). (C2) Neuritic plaque with dystrophic neurites (Bodian stain). (C3) Neurofibrillary tangles (large arrows) and neuropil threads (small arrows) (Bodian stain). From [3]. Free Neuropathology 1:25 (2020) Kurt A. Jellinger doi: https://doi.org/10.17879/freeneuropathology-2020-2945 page 4 of 20 Medical school and beyond “Promotio sub auspiciis Praesidentis rei publicae,” the highest possible distinction for academic In 1949, I entered the Medical Faculty of the achievements in Austria, in medicine since the end University of Vienna, where the circumstances of of World War II. In the meantime, I worked as guest medical education were made far more difficult doctor without salary in the Franz Josef Hospital in due to the sequelae of the war. For example, we Vienna, within the department of Internal Medicine worked in the anatomy theater in winter with and Surgery, directed by Prof.
Recommended publications
  • Peter Riederer
    Profiles (List of Publications) February 25, 2016 Peter Riederer 1 1992 (419) Frölich L, Riederer P (1992) Demenz vom Alzheimer-Typ: Biochemische Befunde und ätiologische Hypothesen. Therapiewoche 42 (9):500-505 (420) Riederer P, Lange KW, Kornhuber J, Danielczyk W (1992) Glutamatergic-Dopaminergic Balance in the Brain. Arzneim-Forsch/Drug Res 42 (I):265-268 (421) Gerlach M, Riederer P (1992) Biochemische Grundlagen der Psychosen. In: Der Medizinische Notfall VI. Proceedings, Interdisziplinäres Forum für Med. Fortbildung, Neuhofen/Ybbs, pp 65-71 (422) Riederer P, Laux G, Pöldinger W (1992) Neuro-Psychopharmaka, Bd. 1, SpringerVerlag WienNewYork (423) Berger W, Riederer P (1992) 10.2 Neurotransmitter-Regelkreise. Riederer P, Laux G, Pöldinger (eds) Neuro-Psychopharmaka, Bd. 1. Springer-Verlag WienNewYork, pp 225-271 (424) Müller WE, Riederer P, Kienzel E (1992) 9. Grundlegende Aspekte zur Neurotransmission. Riederer P, Laux G, Pöldinger (eds) Neuro-Psychopharmaka, Bd. 1. Springer-Verlag WienNewYork, pp 222-248 (425) Sofic E, Riederer P, Schmidt B, Fritze J, Kollegger H, Dierks T, Beckmann H (1992) Biogenic amines and metabolites in CSF from patients with HIV infection. Biogenic Amines 8 (5):293-298 (426) Riederer P, Lange KW (1992) Pathogenesis of Parkinson´s disease. Current Opinion in Neurology and Neurosurgery 5:295-300 (427) Gerlach M, Riederer P, Youdim MBH (1992) The molecular pharmacoloy of L-deprenyl. European Journal of Pharmacology - Molecular Pharmacology Section 226:97-108 (428) Hiemke C, Baumann P, Breyer-Pfaff U, Gold R, Klotz U, Müller-Oerlinghausen B, Rao M-L, Riederer P, Wetzel H, Wiedemann K (1992) Drug Monitoring in Psychiatric Patients: Which Approach is Useful to Improve Psychopharmacotherapy? Pharmacopsychiat 25:72-74 2 (429) Youdim MBH, Riederer P (1992) Iron in the Brain, and Parkinson´s Disease.
    [Show full text]
  • Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson's Disease
    UCSF UC San Francisco Previously Published Works Title Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson's Disease. Permalink https://escholarship.org/uc/item/01d6j0mz Journal Cells, 9(12) ISSN 2073-4409 Authors Plum, Sarah Eggers, Britta Helling, Stefan et al. Publication Date 2020-12-02 DOI 10.3390/cells9122580 Peer reviewed eScholarship.org Powered by the California Digital Library University of California cells Article Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease 1, 1,2, 1 1,2 3 Sarah Plum y, Britta Eggers y , Stefan Helling , Markus Stepath , Carsten Theiss , Renata E. P. Leite 4,5, Mariana Molina 4, Lea T. Grinberg 4,6, Peter Riederer 7,8, Manfred Gerlach 9, 1,2, 1,2, , Caroline May z and Katrin Marcus * z 1 Medizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801 Bochum, Germany; [email protected] (S.P.); [email protected] (B.E.); [email protected] (S.H.); [email protected] (M.S.); [email protected] (C.M.) 2 Medical Proteome Analysis, Center for Proteindiagnostics (PRODI), Ruhr-University Bochum, 44801 Bochum, Germany 3 Department of Cytology, Institute of Anatomy, Ruhr-University Bochum, 44780 Bochum, Germany; [email protected] 4 Department of Pathology, LIM22, University of Sao Paulo Medical School, Sao Paulo 01246-903, Brazil; [email protected] (R.E.P.L.); [email protected] (M.M.); [email protected]
    [Show full text]
  • Treatment for Disease Modification in Chronic Neurodegeneration
    cells Review Perspective: Treatment for Disease Modification in Chronic Neurodegeneration Thomas Müller 1,* , Bernhard Klaus Mueller 1 and Peter Riederer 2,3 1 Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Gartenstr. 1, 13088 Berlin, Germany; [email protected] 2 Center of Mental Health, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Margarete-Höppel-Platz 1, 97080 Würzburg, Germany; [email protected] 3 Department of Psychiatry, Southern Denmark University Odense, J.B. Winslows Vey 18, 5000 Odense, Denmark * Correspondence: [email protected] Abstract: Symptomatic treatments are available for Parkinson’s disease and Alzheimer’s disease. An unmet need is cure or disease modification. This review discusses possible reasons for negative clinical study outcomes on disease modification following promising positive findings from experi- mental research. It scrutinizes current research paradigms for disease modification with antibodies against pathological protein enrichment, such as α-synuclein, amyloid or tau, based on post mortem findings. Instead a more uniform regenerative and reparative therapeutic approach for chronic neurodegenerative disease entities is proposed with stimulation of an endogenously existing repair system, which acts independent of specific disease mechanisms. The repulsive guidance molecule A pathway is involved in the regulation of peripheral and central neuronal restoration. Therapeutic antagonism of repulsive guidance molecule A reverses neurodegeneration according to experimental Citation: Müller, T.; Mueller, B.K.; outcomes in numerous disease models in rodents and monkeys. Antibodies against repulsive guid- Riederer, P. Perspective: Treatment for ance molecule A exist. First clinical studies in neurological conditions with an acute onset are under Disease Modification in Chronic Neurodegeneration. Cells 2021, 10, way.
    [Show full text]
  • Association Between a Null Mutation in the Human Ciliary Neurotrophic Factor (CNTF) Gene and Increased Incidence of Psychiatric Diseases?
    ELSEVIER Neuroscience Letters 203 (1996) 109-110 Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases? Johannes Thome a,*, Johannes Kornhuber a, Alessandra Baumer b, Michael R6sler a, Helmut Beckmann a, Peter Riederer a aDepartment of Psychiatry, University of Wfirzburg, Fiichsleinstrafle 15, 97080 Wfirzburg, Germany blnstitute of Human Genetics, University of Wfirzburg, Am Hubland, 97074 Wiirzburg, Germany Received 16 October 1995; revised version received 6 December 1995; accepted 6 December 1995 Abstract We report a possible association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and psychiatric dis- eases. Prior findings that the mutant allele frequency is not significantly elevated in patients suffering from neurological diseases are confirmed. The frequency of the mutant allele was higher among psychiatric patients (0.192, n = 297) than among healthy controls and neurological patients (0.142, n = 267). This difference (one-tailed 2 x 2 chi-square test, P < 0.05) might be evidence that disturbances in the neurotrophic factor system could play a crucial role in the etiopathogenesis of psychiatric disorders, mainly psychoses. Keywords: Ciliary neurotrophic factor; Genetics; Mutation; Neurodevelopment; Neurotrophic factor; Psychiatry; Psychoses Neurodevelopmental deficits, disturbances of the quency in a Caucasian population was determined for the cell migration and dysconnections of neuronal and glial first time. structures are currently discussed as possible pathome- Inpatients (208 neurological: 112 female, 96 male; chanisms for psychiatric disorders, mainly endogenous and 297 psychiatric: 155 female, 142 male) suffering psychoses including schizophrenia [2,3,9] and manic- from various diseases, as well as 59 age- and sex-matched depressive disorders, severe brain diseases with until now healthy subjects (31 female, 28 male) were examined unknown pathogenesis and putative genetic and environ- (mean age __.
    [Show full text]
  • The Diabetic Brain and Cognition
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by SZTE Publicatio Repozitórium - SZTE - Repository of Publications J Neural Transm DOI 10.1007/s00702-017-1763-2 NEUROLOGY AND PRECLINICAL NEUROLOGICAL STUDIES - REVIEW ARTICLE The diabetic brain and cognition 1 16 2 3 Peter Riederer • Amos D. Korczyn • Sameh S. Ali • Ovidiu Bajenaru • 4 5 7 Mun Seong Choi • Michael Chopp • Vesna Dermanovic-Dobrota • 8,9,10 11 13,14,15 Edna Gru¨nblatt • Kurt A. Jellinger • Mohammad Amjad Kamal • 12 17 19 Warda Kamal • Jerzy Leszek • Tanja Maria Sheldrick-Michel • 20 18 6 21 Gohar Mushtaq • Bernard Meglic • Rachel Natovich • Zvezdan Pirtosek • 22 23 24 Martin Rakusa • Melita Salkovic-Petrisic • Reinhold Schmidt • 25 26 27 Angelika Schmitt • G. Ramachandra Sridhar • La´szlo´ Ve´csei • 28 29 5,29 6 Zyta Beata Wojszel • Hakan Yaman • Zheng G. Zhang • Tali Cukierman-Yaffe Received: 1 June 2017 / Accepted: 13 July 2017 Ó Springer-Verlag GmbH Austria 2017 Abstract The prevalence of both Alzheimer’s disease (AD) Congress on Vascular Disorders and on literature search and vascular dementia (VaD) is increasing with the aging of using PUBMED, it can be concluded that T2DM is a risk the population. Studies from the last several years have factor for both, AD and VaD, based on a pathology of glu- shown that people with diabetes have an increased risk for cose utilization. This pathology is the consequence of a dementia and cognitive impairment. Therefore, the authors disturbance of insulin-related mechanisms leading to brain of this consensus review tried to elaborate on the role of insulin resistance.
    [Show full text]
  • Print Special Issue Flyer
    IMPACT FACTOR 4.879 an Open Access Journal by MDPI In Honor of the 80th Birthday of Professor Peter Riederer Guest Editors: Message from the Guest Editors Prof. Dr. Lars Tönges Dear Colleagues, Department of Neurology, Ruhr- Universität Bochum, Bochum, This issue is dedicated to the 80th birthday of Professor Dr Germany Peter Riederer. [email protected] He is one the most influential experimental researchers in Prof. Dr. Thomas Müller the field of neurochemistry in psychiatry and neurology. St. Joseph Hospital Berlin- His life time achievement is characterised by the Weißensee, Department of Neurology, Berlin, Germany continuous successful approach to combine clinical and experimental research. [email protected] This honorary issue in “Biomolecules” reflects this scientific Prof. Dr. Wilfried Kuhn Leopoldina Hospital Schweinfurt, principle and includes experimental findings and outcomes Schweinfurt, Germany of clinical studies. [email protected] The editors wish Professor Riederer many further fruitful future years and thank him for his continuous support over the years. Deadline for manuscript submissions: Prof. Dr. Lars Tönges 31 December 2021 Prof. Dr. Thomas Müller Prof. Dr. Wilfried Kuhn Guest Editors mdpi.com/si/84176 SpeciaIslsue IMPACT FACTOR 4.879 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Dr. Vladimir N. Uversky Biomolecules is a multidisciplinary open-access journal Department of Molecular that reports on all aspects of research related to biogenic Medicine, USF Health Byrd substances, from small molecules to complex polymers. Alzheimer’s Research Institute, Morsani College of Medicine, We invite manuscripts of high scientific quality that pertain University of South Florida, 12901 to the diverse aspects relevant to organic molecules, Bruce B.
    [Show full text]
  • Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’S Disease
    cells Article Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease 1, 1,2, 1 1,2 3 Sarah Plum y, Britta Eggers y , Stefan Helling , Markus Stepath , Carsten Theiss , Renata E. P. Leite 4,5, Mariana Molina 4, Lea T. Grinberg 4,6, Peter Riederer 7,8, Manfred Gerlach 9, 1,2, 1,2, , Caroline May z and Katrin Marcus * z 1 Medizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801 Bochum, Germany; [email protected] (S.P.); [email protected] (B.E.); [email protected] (S.H.); [email protected] (M.S.); [email protected] (C.M.) 2 Medical Proteome Analysis, Center for Proteindiagnostics (PRODI), Ruhr-University Bochum, 44801 Bochum, Germany 3 Department of Cytology, Institute of Anatomy, Ruhr-University Bochum, 44780 Bochum, Germany; [email protected] 4 Department of Pathology, LIM22, University of Sao Paulo Medical School, Sao Paulo 01246-903, Brazil; [email protected] (R.E.P.L.); [email protected] (M.M.); [email protected] (L.T.G.) 5 Division of Geriatrics, LIM 66, University of Sao Paulo Medical School, Sao Paulo 01246-903, Brazil 6 Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA 94158, USA 7 Center of Mental Health, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, Margarete-Höppel-Platz 1, 97080 Wuerzburg, Germany; [email protected] 8 Psychiatry Department of Clinical Research, University of Southern Denmark Odense University Hospital, Winslows Vey 18, 5000 Odense, Denmark 9 Center of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Wuerzburg, University of Wuerzburg, 97080 Wuerzburg, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-234-32-18106 These authors contributed equally to this work.
    [Show full text]
  • (WFSBP) Guidelines for the Biological Treatment of Alzheimer Disease
    The World Journal of Biological Psychiatry, 2011; 12: 2–32 GUIDELINES World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer’ s disease and other dementias RALF IHL 1 , LUTZ FR Ö LICH 2 , BENGT WINBLAD 3 , LON SCHNEIDER 4 , ALISTAIR BURNS 5 , HANS-J Ü RGEN M Ö LLER 6 & WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR ALZHEIMER’S DISEASE AND ∗ OTHER DEMENTIAS 1 Alexian Hospital Krefeld and Department of Psychiatry, University of Duesseldorf, Germany, 2 Division of Geriatric Psychiatry Central Institute of Mental Health Mannheim University of Heidelberg, Mannheim, Germany, 3 Karolinska Institute, Neurotec, Huddinge, Sweden, 4 University of Southern California Keck School of Medicine, Los Angeles, CA, USA, 5 Psychiatry Research Group, University of Manchester, Manchester, UK, and 6 Department of Psychiatry and Psychotherapy, University of Munich, Munich, Germany Abstract Objectives. To defi ne a practice guideline for biological treatment of dementia and to make transparent the development of the guideline connecting the original data with the resulting recommendations. Methods. This guideline includes pharma- cologic treatment considerations for patients with Alzheimer’s disease, vascular dementia, DLB, and fronto-temporal dementia. Studies were selected that represent double-blind placebo-controlled trials of at least 3 months duration in patients with a diagnosis of dementia according to accepted international diagnostic criteria (for example the NINCDS/ ADRDA or NINDS/AIREN criteria). Moreover, to be included studies had to fulfi ll a restrictive set of methodological criteria. Original studies and not meta-analyses determined the evaluation and the development of recommendations. Results. Antidementia pharmaceuticals neither cure nor arrest the disease.
    [Show full text]
  • Spatial and Temporal Relationships Between Plaques and Tangles in Alzheimer-Pathology Bärbel Schönheit, Rosemarie Zarski, Thomas G
    Neurobiology of Aging 25 (2004) 697–711 Open peer commentary Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology Bärbel Schönheit, Rosemarie Zarski, Thomas G. Ohm∗,1 Department of Clinical Cell and Neurobiology, Institute of Anatomy, Charité, 10098 Berlin, Germany Received 10 September 2002; received in revised form 29 July 2003; accepted 17 September 2003 Abstract One histological hallmark in Alzheimer’s disease is the tangle. The other is the plaque. A widely discussed hypothesis is the “amyloid cascade” assuming that tangle formation is a direct consequence of amyloid plaque formation. The aim of this study was to examine plaques and tangles in a highly defined neuronal circuitry in order to determine their detailed spatial and temporal relationships. We investigated serial sections of the whole hippocampal formation of brains with early Braak-stages (0–III) for tangles only, i.e. one case at stage 0, six at stage I, six at stage II, and nine at stage III. Most cases displayed both plaques and tangles. Four cases of stages 0 and I, three cases with stage II, and even one with stage III, however, did not display plaques. In turn, no plaque was found in the absence of tangles. The spatial relationship indicates that plaques lay in the terminal fields of tangle-bearing neurons. Our analysis suggests that tangles either antecede plaques or—less likely—are independently formed. © 2004 Elsevier Inc. All rights reserved. Keywords: Alzheimer’s disease; Amyloid plaques; ␤A4-peptide; Neurofibrillary tangles; Amyloid cascade hypothesis; Hippocampal formation; Hippocampus; Entorhinal cortex; Time course; Braak staging; Anterograde neurodegeneration; Spatial pattern 1.
    [Show full text]
  • Differential Effects of Neuromelanin and Synthetic Dopamine Melanin On
    Aus der Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Würzburg Direcktor: Professor Dr. med. Dr. h. c. Helmut Beckmann Differential effects of neuromelanin and synthetic dopamine melanin on cell lines Inaugural – Dissertation zur Erlangung der Doktorwürde der Medizinischen Fakultät der Bayerischen Julius-Maximilians-Unversität zu Würzburg vorgelegt von Jie Li aus Tianjin, China Würzburg, November 2004 Referent: Prof. Dipl.-Ing. Dr. techn. Peter Riederer Koreferent: Prof. Dr. W. Roggendorf Dekan: Prof. Dr. med. Georg Ertl Tag der mündlichen Prüfung: 03, 06, 2005 Die Promovendin ist Ärztin Content 1. Introduction.................................................................................................................1 1.1 About Parkinson’s Disease……………………………………………………. 1 1.2 Etiopathogenesis of PD………………………………….………..……………3 1.3 Pathological anatomy of PD ………………………………………….……….5 1.4 Pathogenesis of PD……………………………………………………….……7 1.5 Hypothesis and aims of this project……………………………………..……19 2. Materials and Methods……………………………………………………………..20 2.1 Cell culture as a model of nigral pigmented neurons…………………………..20 2.2 General cell culture methods…………………………………………………...21 2.3 Preparation of melanin pigment..........................................................................23 2.4 Treatment of cells................................................................................................24 2.5 Electron photography………………………………………………………..…25 2.6 Measurement of experimental endpoints……………………………………....26 2.7 Apoptosis
    [Show full text]
  • BOOK of ABSTRACTS OXFORD ENCALS Meeting 2018
    2018 MEETING 20-22 JUNE 2018 BOOK OF ABSTRACTS OXFORD ENCALS Meeting 2018 Acknowledgements ENCALS would like to thank the following sponsors for their generous support of this year’s meeting. Gold Sponsor Silver Sponsors Bronze Sponsors 2 ENCALS Meeting 2018 Poster Session 1: Wednesday 20th June, 18:00 - 19:30 Entrance Hall: A01 Hot-spot KIF5A mutations cause familial ALS David Brenner* (1), Rüstem Yilmaz (1), Kathrin Müller (1), Torsten Grehl (2), Susanne Petri (3), Thomas Meyer (4), Julian Grosskreutz (5), Patrick Weydt (1, 6), Wolfgang Ruf (1), Christoph Neuwirth (7), Markus Weber (7), Susana Pinto (8, 9), Kristl G. Claeys (10, 11, 12), Berthold Schrank (13), Berit Jordan (14), Antje Knehr (1), Kornelia Günther (1), Annemarie Hübers (1), Daniel Zeller (15), The German ALS network MND-NET, Christian Kubisch (16, 17), Sibylle Jablonka (18), Michael Sendtner (18), Thomas Klopstock (19), Mamede de Carvalho (8, 20), Anne Sperfeld (14), Guntram Borck (16), Alexander E. Volk (16, 17), Johannes Dorst (1), Joachim Weis (10), Markus Otto (1), Joachim Schuster (1), Kelly del Tredici (1), Heiko Braak (1), Karin M. Danzer (1), Axel Freischmidt (1), Thomas Meitinger (21), Tim M. Strom (21), Albert C. Ludolph (1), Peter M. Andersen (1, 9), and Jochen H. Weishaupt (1) Heterozygous missense mutations in the N-terminal motor or coiled-coil domains of the kinesin family member 5A (KIF5A) gene cause monogenic spastic paraplegia (HSP10) and Charcot-Marie-Tooth disease type 2 (CMT2). Moreover, heterozygous de novo frame-shift mutations in the C-terminal domain of KIF5A are associated with neonatal intractable myoclonus, a neurodevelopmental syndrome.
    [Show full text]
  • Research Collection
    Research Collection Journal Article Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity Author(s): Bartl, Jasmin; Müller, Thomas; Grünblatt, Edna; Gerlach, Manfred; Riederer, Peter Publication Date: 2014-04 Permanent Link: https://doi.org/10.3929/ethz-b-000082695 Originally published in: Journal of Neural Transmission 121(4), http://doi.org/10.1007/s00702-013-1120-z Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library J Neural Transm (2014) 121:379–383 DOI 10.1007/s00702-013-1120-z NEUROLOGY AND PRECLINICAL NEUROLOGICAL STUDIES - SHORT COMMUNICATION Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity Jasmin Bartl • Thomas Mu¨ller • Edna Gru¨nblatt • Manfred Gerlach • Peter Riederer Received: 28 September 2013 / Accepted: 8 November 2013 / Published online: 23 November 2013 Ó Springer-Verlag Wien 2013 Abstract Patients with Parkinson’s disease receive common in patients with Parkinson’s disease (PD) selective irreversible monoamine oxidase (MAO)-B inhib- (Deftereos et al. 2012). Two isoforms of the enzyme, itors, but their effects on MAO-A activity are not known MAO-A and MAO-B, are known according to MAO (EC during long-term application. We determined MAO-A 1.4.3.4) substrate and inhibitor specificities (Johnston inhibition in plasma samples from patients with MAO-B 1968). MAO-A is primarily located in the periphery with inhibitor intake or without MAO-B inhibitor treatment and approximately 80 % of total MAO activity in the gastro- from healthy controls.
    [Show full text]